GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (MEX:EW) » Definitions » Cyclically Adjusted Price-to-FCF

Edwards Lifesciences (MEX:EW) Cyclically Adjusted Price-to-FCF : 68.33 (As of Jun. 25, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Edwards Lifesciences Cyclically Adjusted Price-to-FCF?

As of today (2024-06-25), Edwards Lifesciences's current share price is MXN1623.50. Edwards Lifesciences's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was MXN23.76. Edwards Lifesciences's Cyclically Adjusted Price-to-FCF for today is 68.33.

The historical rank and industry rank for Edwards Lifesciences's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

MEX:EW' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 36.33   Med: 69.21   Max: 113.15
Current: 62.73

During the past years, Edwards Lifesciences's highest Cyclically Adjusted Price-to-FCF was 113.15. The lowest was 36.33. And the median was 69.21.

MEX:EW's Cyclically Adjusted Price-to-FCF is ranked worse than
71.19% of 236 companies
in the Medical Devices & Instruments industry
Industry Median: 42.03 vs MEX:EW: 62.73

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Edwards Lifesciences's adjusted free cash flow per share data for the three months ended in Mar. 2024 was MXN-3.813. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is MXN23.76 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Edwards Lifesciences Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Edwards Lifesciences's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Cyclically Adjusted Price-to-FCF Chart

Edwards Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 90.88 97.20 108.59 54.10 52.26

Edwards Lifesciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.86 66.13 46.94 52.26 66.48

Competitive Comparison of Edwards Lifesciences's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Edwards Lifesciences's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edwards Lifesciences's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's Cyclically Adjusted Price-to-FCF falls into.



Edwards Lifesciences Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Edwards Lifesciences's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=1623.50/23.76
=68.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edwards Lifesciences's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Edwards Lifesciences's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-3.813/131.7762*131.7762
=-3.813

Current CPI (Mar. 2024) = 131.7762.

Edwards Lifesciences Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 15.336 100.560 20.097
201409 -0.122 100.428 -0.160
201412 1.073 99.070 1.427
201503 1.209 99.621 1.599
201506 3.608 100.684 4.722
201509 4.521 100.392 5.934
201512 1.622 99.792 2.142
201603 2.092 100.470 2.744
201606 3.180 101.688 4.121
201609 4.657 101.861 6.025
201612 4.345 101.863 5.621
201703 3.182 102.862 4.076
201706 3.799 103.349 4.844
201709 7.692 104.136 9.734
201712 9.262 104.011 11.734
201803 2.959 105.290 3.703
201806 2.675 106.317 3.316
201809 7.522 106.507 9.307
201812 7.256 105.998 9.021
201903 -1.752 107.251 -2.153
201906 8.134 108.070 9.918
201909 11.207 108.329 13.633
201912 9.798 108.420 11.909
202003 4.611 108.902 5.580
202006 4.577 108.767 5.545
202009 3.949 109.815 4.739
202012 8.882 109.897 10.650
202103 6.298 111.754 7.426
202106 14.436 114.631 16.595
202109 15.338 115.734 17.464
202112 9.085 117.630 10.178
202203 6.979 121.301 7.582
202206 9.281 125.017 9.783
202209 8.052 125.227 8.473
202212 6.129 125.222 6.450
202303 7.067 127.348 7.313
202306 -0.034 128.729 -0.035
202309 10.180 129.860 10.330
202312 0.979 129.419 0.997
202403 -3.813 131.776 -3.813

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Edwards Lifesciences  (MEX:EW) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Edwards Lifesciences Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Edwards Lifesciences (MEX:EW) Business Description

Address
One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.